nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—HTR2C—bipolar disorder	0.774	1	CbGaD
Agomelatine—HTR2C—telencephalic ventricle—bipolar disorder	0.00757	0.211	CbGeAlD
Agomelatine—CYP1A2—urine—bipolar disorder	0.00443	0.124	CbGeAlD
Agomelatine—MTNR1A—nervous system—bipolar disorder	0.00438	0.122	CbGeAlD
Agomelatine—CYP2C9—urine—bipolar disorder	0.00421	0.117	CbGeAlD
Agomelatine—MTNR1A—brain—bipolar disorder	0.00335	0.0934	CbGeAlD
Agomelatine—CYP1A2—blood plasma—bipolar disorder	0.00231	0.0645	CbGeAlD
Agomelatine—CYP2C9—blood plasma—bipolar disorder	0.0022	0.0613	CbGeAlD
Agomelatine—HTR2B—adrenal cortex—bipolar disorder	0.00172	0.048	CbGeAlD
Agomelatine—HTR2B—thyroid gland—bipolar disorder	0.0012	0.0334	CbGeAlD
Agomelatine—HTR2C—nervous system—bipolar disorder	0.00107	0.0299	CbGeAlD
Agomelatine—HTR2B—nervous system—bipolar disorder	0.00101	0.0281	CbGeAlD
Agomelatine—HTR2C—brain—bipolar disorder	0.00082	0.0229	CbGeAlD
Agomelatine—CYP1A2—thyroid gland—bipolar disorder	0.000818	0.0228	CbGeAlD
Agomelatine—HTR2B—brain—bipolar disorder	0.00077	0.0215	CbGeAlD
Agomelatine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000121	0.000636	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—RGS4—bipolar disorder	0.00012	0.00063	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—HTR2A—bipolar disorder	0.00012	0.000629	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—HTR2A—bipolar disorder	0.000119	0.000625	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—HTR2A—bipolar disorder	0.000119	0.000625	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HTR1A—bipolar disorder	0.000119	0.000623	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HTR1A—bipolar disorder	0.000119	0.000623	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—DRD3—bipolar disorder	0.000118	0.00062	CbGpPWpGaD
Agomelatine—CYP1A2—Phase II conjugation—COMT—bipolar disorder	0.000118	0.000619	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TAC1—bipolar disorder	0.000117	0.000613	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TAC1—bipolar disorder	0.000117	0.000613	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.000115	0.000602	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—DRD4—bipolar disorder	0.000115	0.000602	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—DRD1—bipolar disorder	0.000115	0.000602	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—DRD1—bipolar disorder	0.000115	0.000602	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HTR2C—bipolar disorder	0.000115	0.000602	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HTR2C—bipolar disorder	0.000115	0.000602	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.000113	0.000594	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NTRK2—bipolar disorder	0.000112	0.000585	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NTRK2—bipolar disorder	0.000112	0.000585	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—DRD5—bipolar disorder	0.000111	0.000584	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—DRD3—bipolar disorder	0.000111	0.000583	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—DRD3—bipolar disorder	0.000111	0.000583	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—GSK3A—bipolar disorder	0.000111	0.00058	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—GSK3A—bipolar disorder	0.000111	0.00058	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—RGS4—bipolar disorder	0.000109	0.000572	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—DGKH—bipolar disorder	0.000108	0.000567	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—DRD4—bipolar disorder	0.000108	0.000566	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—DRD4—bipolar disorder	0.000108	0.000566	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.000107	0.000562	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—DRD2—bipolar disorder	0.000107	0.000561	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—POMC—bipolar disorder	0.000105	0.000549	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—POMC—bipolar disorder	0.000105	0.000549	CbGpPWpGaD
Agomelatine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000104	0.000544	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—HTR1A—bipolar disorder	0.000102	0.000535	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—ADCY2—bipolar disorder	0.000101	0.000532	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—ADCY2—bipolar disorder	0.000101	0.000532	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TCF7L2—bipolar disorder	0.000101	0.00053	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TCF7L2—bipolar disorder	0.000101	0.00053	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—TAC1—bipolar disorder	0.0001	0.000527	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—DRD2—bipolar disorder	0.0001	0.000527	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—DRD2—bipolar disorder	0.0001	0.000527	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—DRD5—bipolar disorder	9.88e-05	0.000518	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—DRD1—bipolar disorder	9.85e-05	0.000517	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	9.83e-05	0.000516	CbGpPWpGaD
Agomelatine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	9.83e-05	0.000516	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—DGKH—bipolar disorder	9.81e-05	0.000515	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—RGS4—bipolar disorder	9.69e-05	0.000508	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—DRD3—bipolar disorder	9.54e-05	0.0005	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—bipolar disorder	9.51e-05	0.000499	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—POMC—bipolar disorder	9.51e-05	0.000499	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—POMC—bipolar disorder	9.51e-05	0.000499	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—TRPC3—bipolar disorder	9.28e-05	0.000487	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	9.26e-05	0.000486	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—DRD4—bipolar disorder	9.26e-05	0.000486	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NTRK1—bipolar disorder	9.09e-05	0.000477	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NTRK1—bipolar disorder	9.09e-05	0.000477	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—DRD5—bipolar disorder	8.97e-05	0.000471	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—ADM—bipolar disorder	8.85e-05	0.000465	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—S100B—bipolar disorder	8.84e-05	0.000464	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—S100B—bipolar disorder	8.84e-05	0.000464	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—RGS4—bipolar disorder	8.8e-05	0.000462	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	8.63e-05	0.000453	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PDE4B—bipolar disorder	8.63e-05	0.000453	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—TSHB—bipolar disorder	8.63e-05	0.000453	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—TACR1—bipolar disorder	8.63e-05	0.000453	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—DRD2—bipolar disorder	8.62e-05	0.000453	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—TRPC3—bipolar disorder	8.43e-05	0.000442	CbGpPWpGaD
Agomelatine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	8.4e-05	0.000441	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—COMT—bipolar disorder	8.07e-05	0.000424	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—ADM—bipolar disorder	8.04e-05	0.000422	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—MAOA—bipolar disorder	8.02e-05	0.000421	CbGpPWpGaD
Agomelatine—CYP2C9—Metapathway biotransformation—COMT—bipolar disorder	7.96e-05	0.000418	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	7.93e-05	0.000416	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	7.85e-05	0.000412	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—TSHB—bipolar disorder	7.84e-05	0.000411	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PDE4B—bipolar disorder	7.84e-05	0.000411	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—TACR1—bipolar disorder	7.84e-05	0.000411	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AKR1C4—bipolar disorder	7.8e-05	0.00041	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NRG1—bipolar disorder	7.8e-05	0.000409	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NRG1—bipolar disorder	7.8e-05	0.000409	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	7.75e-05	0.000407	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—TRPC3—bipolar disorder	7.49e-05	0.000393	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—HTR2A—bipolar disorder	7.49e-05	0.000393	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	7.37e-05	0.000387	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DGKH—bipolar disorder	7.18e-05	0.000377	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—ADM—bipolar disorder	7.14e-05	0.000375	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—HTR1A—bipolar disorder	7.14e-05	0.000375	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—TAC1—bipolar disorder	7.03e-05	0.000369	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HTR2A—bipolar disorder	7.03e-05	0.000369	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HTR2A—bipolar disorder	7.03e-05	0.000369	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—TSHB—bipolar disorder	6.96e-05	0.000365	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PDE4B—bipolar disorder	6.96e-05	0.000365	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—TACR1—bipolar disorder	6.96e-05	0.000365	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—IMPA2—bipolar disorder	6.91e-05	0.000363	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—COMT—bipolar disorder	6.9e-05	0.000362	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—HTR2C—bipolar disorder	6.9e-05	0.000362	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—DRD1—bipolar disorder	6.9e-05	0.000362	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—MAOA—bipolar disorder	6.85e-05	0.00036	CbGpPWpGaD
Agomelatine—CYP1A2—Metapathway biotransformation—COMT—bipolar disorder	6.8e-05	0.000357	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—TRPC3—bipolar disorder	6.8e-05	0.000357	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—DRD3—bipolar disorder	6.68e-05	0.000351	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	6.62e-05	0.000348	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DRD5—bipolar disorder	6.57e-05	0.000345	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—ADM—bipolar disorder	6.49e-05	0.00034	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—HTR1A—bipolar disorder	6.49e-05	0.00034	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—DRD4—bipolar disorder	6.49e-05	0.00034	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RGS4—bipolar disorder	6.44e-05	0.000338	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—TAC1—bipolar disorder	6.39e-05	0.000335	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	6.34e-05	0.000332	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PDE4B—bipolar disorder	6.32e-05	0.000332	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—TSHB—bipolar disorder	6.32e-05	0.000332	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—TACR1—bipolar disorder	6.32e-05	0.000332	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AKR1C4—bipolar disorder	6.3e-05	0.00033	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—DRD1—bipolar disorder	6.26e-05	0.000329	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—HTR2C—bipolar disorder	6.26e-05	0.000329	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—ADCY2—bipolar disorder	6.1e-05	0.00032	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—DRD3—bipolar disorder	6.07e-05	0.000318	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—DRD2—bipolar disorder	6.04e-05	0.000317	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—HTR2A—bipolar disorder	6.04e-05	0.000317	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—POMC—bipolar disorder	5.98e-05	0.000314	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—IMPA2—bipolar disorder	5.9e-05	0.00031	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—DRD4—bipolar disorder	5.89e-05	0.000309	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DGKH—bipolar disorder	5.79e-05	0.000304	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—HTR1A—bipolar disorder	5.76e-05	0.000302	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—TAC1—bipolar disorder	5.67e-05	0.000298	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—GSK3B—bipolar disorder	5.66e-05	0.000297	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—GSK3B—bipolar disorder	5.66e-05	0.000297	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—POMC—bipolar disorder	5.62e-05	0.000295	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—POMC—bipolar disorder	5.62e-05	0.000295	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—INS—bipolar disorder	5.58e-05	0.000293	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—INS—bipolar disorder	5.58e-05	0.000293	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—DRD1—bipolar disorder	5.56e-05	0.000292	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—ADCY2—bipolar disorder	5.54e-05	0.000291	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—DRD2—bipolar disorder	5.49e-05	0.000288	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—DRD3—bipolar disorder	5.39e-05	0.000283	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DRD5—bipolar disorder	5.3e-05	0.000278	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	5.25e-05	0.000276	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—HTR1A—bipolar disorder	5.23e-05	0.000275	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—DRD4—bipolar disorder	5.23e-05	0.000275	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—POMC—bipolar disorder	5.22e-05	0.000274	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RGS4—bipolar disorder	5.2e-05	0.000273	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—TAC1—bipolar disorder	5.15e-05	0.00027	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—DRD1—bipolar disorder	5.05e-05	0.000265	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TRPC3—bipolar disorder	4.98e-05	0.000261	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—ADCY2—bipolar disorder	4.92e-05	0.000258	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—DRD3—bipolar disorder	4.89e-05	0.000257	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—DRD2—bipolar disorder	4.87e-05	0.000256	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—POMC—bipolar disorder	4.82e-05	0.000253	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—DRD4—bipolar disorder	4.75e-05	0.000249	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADM—bipolar disorder	4.75e-05	0.000249	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—IMPA1—bipolar disorder	4.67e-05	0.000245	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PDE4B—bipolar disorder	4.63e-05	0.000243	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TSHB—bipolar disorder	4.63e-05	0.000243	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TACR1—bipolar disorder	4.63e-05	0.000243	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	4.56e-05	0.000239	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	4.49e-05	0.000235	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—ADCY2—bipolar disorder	4.47e-05	0.000235	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—POMC—bipolar disorder	4.46e-05	0.000234	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—DRD2—bipolar disorder	4.43e-05	0.000232	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—HTR2A—bipolar disorder	4.23e-05	0.000222	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TRPC3—bipolar disorder	4.02e-05	0.000211	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—IMPA1—bipolar disorder	3.99e-05	0.000209	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NDUFV2—bipolar disorder	3.97e-05	0.000208	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	3.9e-05	0.000205	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AKR1C4—bipolar disorder	3.84e-05	0.000202	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—HTR2A—bipolar disorder	3.84e-05	0.000202	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADM—bipolar disorder	3.83e-05	0.000201	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HTR1A—bipolar disorder	3.83e-05	0.000201	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TAC1—bipolar disorder	3.77e-05	0.000198	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TACR1—bipolar disorder	3.73e-05	0.000196	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PDE4B—bipolar disorder	3.73e-05	0.000196	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TSHB—bipolar disorder	3.73e-05	0.000196	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HTR2C—bipolar disorder	3.7e-05	0.000194	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DRD1—bipolar disorder	3.7e-05	0.000194	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NTRK2—bipolar disorder	3.6e-05	0.000189	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DRD3—bipolar disorder	3.58e-05	0.000188	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GSK3A—bipolar disorder	3.57e-05	0.000187	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DRD4—bipolar disorder	3.48e-05	0.000183	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NR1D1—bipolar disorder	3.45e-05	0.000181	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—HTR2A—bipolar disorder	3.41e-05	0.000179	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NDUFV2—bipolar disorder	3.39e-05	0.000178	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—POMC—bipolar disorder	3.38e-05	0.000177	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NCAN—bipolar disorder	3.3e-05	0.000173	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AKR1C4—bipolar disorder	3.28e-05	0.000172	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADCY2—bipolar disorder	3.27e-05	0.000172	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TCF7L2—bipolar disorder	3.26e-05	0.000171	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DRD2—bipolar disorder	3.24e-05	0.00017	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SLC5A3—bipolar disorder	3.23e-05	0.00017	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—HTR2A—bipolar disorder	3.1e-05	0.000163	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HTR1A—bipolar disorder	3.09e-05	0.000162	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—POMC—bipolar disorder	3.07e-05	0.000161	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TAC1—bipolar disorder	3.04e-05	0.00016	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DRD1—bipolar disorder	2.99e-05	0.000157	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NR1D1—bipolar disorder	2.95e-05	0.000155	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NTRK1—bipolar disorder	2.93e-05	0.000154	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NTRK2—bipolar disorder	2.9e-05	0.000152	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DRD3—bipolar disorder	2.89e-05	0.000152	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GSK3A—bipolar disorder	2.88e-05	0.000151	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—S100B—bipolar disorder	2.85e-05	0.00015	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NCAN—bipolar disorder	2.82e-05	0.000148	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DRD4—bipolar disorder	2.81e-05	0.000147	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SLC5A3—bipolar disorder	2.76e-05	0.000145	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—POMC—bipolar disorder	2.73e-05	0.000143	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADCY2—bipolar disorder	2.64e-05	0.000139	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TCF7L2—bipolar disorder	2.63e-05	0.000138	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DRD2—bipolar disorder	2.61e-05	0.000137	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NRG1—bipolar disorder	2.52e-05	0.000132	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—POMC—bipolar disorder	2.48e-05	0.00013	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NTRK1—bipolar disorder	2.37e-05	0.000124	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CLOCK—bipolar disorder	2.34e-05	0.000123	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—S100B—bipolar disorder	2.3e-05	0.000121	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TSHB—bipolar disorder	2.28e-05	0.00012	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TPH2—bipolar disorder	2.28e-05	0.00012	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CACNB2—bipolar disorder	2.28e-05	0.00012	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HTR2A—bipolar disorder	2.27e-05	0.000119	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—DPYD—bipolar disorder	2.24e-05	0.000118	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CACNA1C—bipolar disorder	2.08e-05	0.000109	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	2.03e-05	0.000107	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NRG1—bipolar disorder	2.03e-05	0.000107	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	2e-05	0.000105	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CLOCK—bipolar disorder	2e-05	0.000105	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TSHB—bipolar disorder	1.95e-05	0.000102	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CACNB2—bipolar disorder	1.95e-05	0.000102	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TPH2—bipolar disorder	1.95e-05	0.000102	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—DPYD—bipolar disorder	1.92e-05	0.000101	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HTR2A—bipolar disorder	1.83e-05	9.61e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GSK3B—bipolar disorder	1.83e-05	9.59e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SNAP25—bipolar disorder	1.82e-05	9.56e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—POMC—bipolar disorder	1.81e-05	9.51e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—INS—bipolar disorder	1.8e-05	9.46e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CACNA1C—bipolar disorder	1.78e-05	9.35e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	1.74e-05	9.11e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	1.71e-05	8.99e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ADCY2—bipolar disorder	1.61e-05	8.46e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SNAP25—bipolar disorder	1.56e-05	8.17e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GSK3B—bipolar disorder	1.47e-05	7.74e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—POMC—bipolar disorder	1.46e-05	7.67e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—INS—bipolar disorder	1.45e-05	7.63e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—COMT—bipolar disorder	1.38e-05	7.25e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ADCY2—bipolar disorder	1.38e-05	7.23e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MAOA—bipolar disorder	1.37e-05	7.2e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—COMT—bipolar disorder	1.18e-05	6.19e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MAOA—bipolar disorder	1.17e-05	6.15e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MTHFR—bipolar disorder	1.12e-05	5.86e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MTHFR—bipolar disorder	9.54e-06	5.01e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—POMC—bipolar disorder	8.93e-06	4.68e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—INS—bipolar disorder	8.88e-06	4.66e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—POMC—bipolar disorder	7.63e-06	4e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—INS—bipolar disorder	7.59e-06	3.98e-05	CbGpPWpGaD
